First-onset major depression during the COVID-19 pandemic: A predictive machine learning model.
COVID-19
Depression
First-onset
General population
Machine learning
Predictive model
Journal
Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073
Informations de publication
Date de publication:
01 08 2022
01 08 2022
Historique:
received:
24
01
2022
revised:
20
04
2022
accepted:
24
04
2022
pubmed:
1
5
2022
medline:
9
6
2022
entrez:
30
4
2022
Statut:
ppublish
Résumé
This study longitudinally evaluated first-onset major depression rates during the pandemic in Italian adults without any current clinician-diagnosed psychiatric disorder and created a predictive machine learning model (MLM) to evaluate subsequent independent samples. An online, self-reported survey was released during two pandemic periods (May to June and September to October 2020). Provisional diagnoses of major depressive disorder (PMDD) were determined using a diagnostic algorithm based on the DSM criteria of the Patient Health Questionnaire-9 to maximize specificity. Gradient-boosted decision trees and the SHapley Additive exPlanations technique created the MLM and estimated each variable's predictive contribution. There were 3532 participants in the study. The final sample included 633 participants in the first wave (FW) survey and 290 in the second (SW). First-onset PMDD was found in 7.4% of FW participants and 7.2% of the SW. The final MLM, trained on the FW, displayed a sensitivity of 76.5% and a specificity of 77.8% when tested on the SW. The main factors identified in the MLM were low resilience, being an undergraduate student, being stressed by pandemic-related conditions, and low satisfaction with usual sleep before the pandemic and support from relatives. Current smoking and taking medication for medical conditions also contributed, albeit to a lesser extent. Small sample size; self-report assessment; data covering 2020 only. Rates of first-onset PMDD among Italians during the first phases of the pandemic were considerable. Our MLM displayed a good predictive performance, suggesting potential goals for depression-preventive interventions during public health crises.
Sections du résumé
BACKGROUND
This study longitudinally evaluated first-onset major depression rates during the pandemic in Italian adults without any current clinician-diagnosed psychiatric disorder and created a predictive machine learning model (MLM) to evaluate subsequent independent samples.
METHODS
An online, self-reported survey was released during two pandemic periods (May to June and September to October 2020). Provisional diagnoses of major depressive disorder (PMDD) were determined using a diagnostic algorithm based on the DSM criteria of the Patient Health Questionnaire-9 to maximize specificity. Gradient-boosted decision trees and the SHapley Additive exPlanations technique created the MLM and estimated each variable's predictive contribution.
RESULTS
There were 3532 participants in the study. The final sample included 633 participants in the first wave (FW) survey and 290 in the second (SW). First-onset PMDD was found in 7.4% of FW participants and 7.2% of the SW. The final MLM, trained on the FW, displayed a sensitivity of 76.5% and a specificity of 77.8% when tested on the SW. The main factors identified in the MLM were low resilience, being an undergraduate student, being stressed by pandemic-related conditions, and low satisfaction with usual sleep before the pandemic and support from relatives. Current smoking and taking medication for medical conditions also contributed, albeit to a lesser extent.
LIMITATIONS
Small sample size; self-report assessment; data covering 2020 only.
CONCLUSIONS
Rates of first-onset PMDD among Italians during the first phases of the pandemic were considerable. Our MLM displayed a good predictive performance, suggesting potential goals for depression-preventive interventions during public health crises.
Identifiants
pubmed: 35489559
pii: S0165-0327(22)00489-X
doi: 10.1016/j.jad.2022.04.145
pmc: PMC9044654
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
75-86Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.
Références
Neuropsychiatr Dis Treat. 2020 Sep 17;16:2111-2118
pubmed: 32982249
Int J Environ Res Public Health. 2020 May 02;17(9):
pubmed: 32370116
J Clin Med. 2020 Dec 25;10(1):
pubmed: 33375763
Disaster Med Public Health Prep. 2011 Dec;5(4):280-6
pubmed: 22146666
Front Psychol. 2020 Nov 05;11:586202
pubmed: 33240178
Psychiatry Res Commun. 2021 Dec;1(2):100012
pubmed: 34977911
Front Psychiatry. 2021 Dec 16;12:790974
pubmed: 34975589
Brain Behav Immun. 2020 Oct;89:531-542
pubmed: 32485289
JAMA Netw Open. 2020 Sep 1;3(9):e2019686
pubmed: 32876685
CNS Spectr. 2022 Jun;27(3):258-259
pubmed: 33300484
J Affect Disord. 2021 Oct 1;293:295-304
pubmed: 34225209
J Neurosci Rural Pract. 2020 Oct;11(4):519-525
pubmed: 33144785
J Affect Disord. 2021 Feb 15;281:91-98
pubmed: 33310451
Psychol Trauma. 2015 May;7(3):252-8
pubmed: 25961118
J Clin Med. 2020 Oct 19;9(10):
pubmed: 33086558
Int J Mol Sci. 2021 Jul 06;22(14):
pubmed: 34298890
Psychiatry Res. 2020 Aug;290:113172
pubmed: 32512357
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Global Health. 2020 Jul 6;16(1):57
pubmed: 32631403
Br J Health Psychol. 2020 Nov;25(4):865-874
pubmed: 32415914
Soc Psychiatry Psychiatr Epidemiol. 2006 Nov;41(11):853-61
pubmed: 16915360
J Affect Disord. 2021 Jan 1;278:66-67
pubmed: 32950845
Psychosom Med. 2019 Apr;81(3):246-255
pubmed: 30720699
Front Psychol. 2021 Jan 22;11:618509
pubmed: 33551929
Transl Psychiatry. 2021 Oct 5;11(1):508
pubmed: 34611129
J Affect Disord. 2020 Feb 15;263:754-761
pubmed: 31630828
J Neuroinflammation. 2021 Feb 16;18(1):45
pubmed: 33593388
Lancet Psychiatry. 2022 Feb;9(2):137-150
pubmed: 35026139
Psychiatry Res. 2020 Sep;291:113190
pubmed: 32563745
BMC Psychiatry. 2016 Nov 5;16(1):375
pubmed: 27816065
Psychol Med. 2018 Apr;48(5):705-713
pubmed: 28967349
Clin Psychopharmacol Neurosci. 2021 Nov 30;19(4):780-785
pubmed: 34690132
Int J Environ Res Public Health. 2020 Jul 08;17(14):
pubmed: 32650522
Psychother Psychosom. 2020;89(1):25-37
pubmed: 31593971
Front Psychiatry. 2021 Dec 14;12:783776
pubmed: 34970167
Int J Behav Med. 2008;15(3):194-200
pubmed: 18696313
Front Psychol. 2020 Jan 10;10:2970
pubmed: 31998200
Annu Rev Public Health. 2014;35:169-83
pubmed: 24159920
J Neuropsychiatry Clin Neurosci. 2022 Summer;34(3):233-246
pubmed: 35306830
Soc Work Public Health. 2017 Jan 2;32(1):65-76
pubmed: 27467596
Psychol Psychother. 2019 Sep;92(3):299-341
pubmed: 29888437
Int J Environ Res Public Health. 2021 Jul 02;18(13):
pubmed: 34281040
Int J Mol Sci. 2021 Nov 12;22(22):
pubmed: 34830130
Front Psychol. 2020 Aug 31;11:2195
pubmed: 32982888
BMJ Open. 2017 Jun 10;7(6):e015156
pubmed: 28601831
Front Psychol. 2021 Jun 14;12:660628
pubmed: 34194364
Front Public Health. 2021 Jun 10;9:674665
pubmed: 34178930
Front Psychiatry. 2020 Aug 07;11:790
pubmed: 32848952
Dialogues Clin Neurosci. 2008;10(3):329-36
pubmed: 18979946
Psychol Med. 2013 Feb;43(2):303-16
pubmed: 22640506
Front Psychiatry. 2022 Feb 03;12:792925
pubmed: 35185638
Twin Res Hum Genet. 2019 Jun;22(3):140-146
pubmed: 31203833
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
Int J Environ Res Public Health. 2020 Nov 05;17(21):
pubmed: 33167479
Psychiatry Res. 2020 Oct;292:113345
pubmed: 32745794
J Clin Med. 2021 Aug 02;10(15):
pubmed: 34362224
Front Psychol. 2021 Jul 14;12:669119
pubmed: 34335381
Brain Behav Immun. 2020 Jul;87:100-106
pubmed: 32353518
J Affect Disord. 2011 Dec;135(1-3):10-9
pubmed: 21300408
Depress Anxiety. 2020 Mar;37(3):202-213
pubmed: 31682327
Front Psychol. 2021 Dec 15;12:734264
pubmed: 34975624
PLoS One. 2021 Mar 11;16(3):e0247997
pubmed: 33705439
Front Psychol. 2020 Nov 04;11:576485
pubmed: 33250818
Brain Behav Immun. 2020 Jul;87:172-176
pubmed: 32405150
J Dermatolog Treat. 2022 Mar;33(2):1079-1083
pubmed: 32705945
Perspect Psychol Sci. 2019 Sep;14(5):765-777
pubmed: 31365841
Psychiatry Res. 2021 Jan;295:113599
pubmed: 33285346
J Cell Mol Med. 2019 Apr;23(4):2324-2332
pubmed: 30734486
J Epidemiol Community Health. 2014 May;68(5):418-24
pubmed: 24391206
Med Sci Monit. 2020 Apr 26;26:e924609
pubmed: 32335579